KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma

American Journal of Pathology

Volumn 159, Issue 5, 2001, Pages 1629-1634

  Liu, Fu Shing ^a,b   Chen, Jung Ta ^a,b   Dong, Jin Tang ^c   Hsieh, Yeun Ting ^a   Lin, Ai Jane ^a   Ho, Esther Shih Chu ^a,b   Hung, Man Jung ^a   Lu, Chien Hsing ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; COMPLEMENTARY DNA; GENE PRODUCT; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY C 16; RNA; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 11P; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS INHIBITION; METASTASIS SUPPRESSOR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

EID: 0035152003     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63009-X     Document Type: Article

References (36)

1. Cervical intraepithelial neoplasia and cervical cancer
2. Cervical cancer
3. The E6 oncoprotein encoded by human papilloma virus types 16 and 18 promotes the degradation of p53
4. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
5. HPV in the pathogenesis of anogenital cancer
6. Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix?
7. Amplification of the c-myc proto-oncogene in cervical carcinoma
8. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix
9. Abnormal fhit expression in malignant and premalignant lesions of the cervix
10. FHIT alterations in cancerous and non-cancerous cervical epithelium
11. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
12. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
13. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
14. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression
15. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases
16. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases
17. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers
18. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients
19. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer
20. KAI1, A new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma
21. Loss of KAI1 expression in the progression of colorectal cancer
22. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma
23. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma
24. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms
25. Real time quantitative PCR
26. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction
27. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
28. Genetic factors and metastatic potential of prostatic cancer
29. MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues
30. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: An association of CD9 with α3β1 integrin
31. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines
32. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53
33. Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer
34. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines
35. Nm23 expression in endometrial and cervical cancer: Inverse correlation with lymph node involvement and myometrial invasion
36. nm23 expression in carcinoma of the uterine cervix